Navigation Links
Virtual Ports Receives Patent Approvals in the United States and Japan
Date:1/29/2013

CAESAREA, Israel, January 29, 2013 /PRNewswire/ --

Virtual Ports Ltd. announced today the receipt of three additional patents covering two of its core products: the EndoGrab™ and the EndoClear™.

Two new patents, one in the U.S. and one in Japan, cover the method, concept, and design of the EndoGrab™ device. The EndoGrab™, which has already been used in more than 10,000 laparoscopic surgeries worldwide, allows surgeons to retract internal organs and anchor them to the inside of the abdominal wall during laparoscopic procedures, reducing the number of ports, incisions and personnel required to perform the procedure. This is a significant improvement to the standard procedure, which requires several incisions in the abdominal wall in order to accommodate all the instruments required to perform laparoscopic surgery. The EndoGrab™ is currently being sold in the U.S., Europe, Japan and Korea.

The Company also received a new U.S. patent protecting the concept and mechanical design of the EndoClear™. This miniature cleaning station for the endoscope lens can be anchored to the abdominal wall so that the lens can be cleaned rapidly and efficiently without having to be removed from the abdominal cavity.

Dan Shwarzman , CEO of Virtual Ports, notes: "We are delighted with the official recognition of the Company's developments and believe that these patents, together with other applications submitted in the United States, Japan, and Europe, protect the Company's intellectual property and form a significant barrier to potential competitors looking for a solution to a well-known and familiar need."

Virtual Ports develops, manufactures, and markets medical devices for use in laparoscopic surgery, a procedure in which surgery is performed by inserting a video camera and thin medical instruments inserted into the abdominal cavity through a number of small incisions in the abdominal wall. Virtual Ports, started in the Misgav Venture Accelerator, was established in 2006 and began marketing its products three years ago. Its customers include leading hospitals and medical centers throughout the world. The major investors in the company are The Trendlines Group, Virginia Life Science Investments LLC, and KIG.

 

For Media Relations:

Efrat Kaduri | Ofir Shpigel Media and Public Relations| +972-4-9535030
Efrat@ofirpr.co.il


'/>"/>
SOURCE Virtual Ports Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Novelos Therapeutics to Present at LHA Life Sciences & Medical Technologies Virtual Conference on June 28
2. LHA Life Sciences & Medical Technologies Virtual Conference
3. Updated: LHA Life Sciences & Medical Technologies Virtual Conference
4. VirtualScopics Schedules Second Quarter 2012 Earnings Announcement
5. FDAnews Announces Medical Device Mobile Apps Virtual Conference
6. VirtualScopics Reports 2nd Quarter 2012 Results
7. Express Scripts Launches Virtual Coaching To Help Patients Better Understand Therapy
8. Sentara Healthcare, MDLIVE Forge Unique Equity Partnership in Virtual Medicine
9. Global Virtual Reality (VR) in Healthcare Industry
10. VirtualScopics Announces Receipt of Notice from Nasdaq
11. Online Career Service Holds Third Virtual Job Summit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... 2016 Wegener Polyangiitis - Pipeline Review, ... ,Wegener Polyangiitis - Pipeline Review, H2 2015, provides ... This report provides comprehensive information on the ... analysis at various stages, therapeutics assessment by drug ... (RoA) and molecule type, along with latest updates, ...
(Date:2/4/2016)... -- Omnicell, Inc. (NASDAQ: OMCL ), a leading provider of ... announced results for its fiscal year and fourth quarter ... --> GAAP results: Revenue for the fourth quarter ... 4.1% from the third quarter of 2015, and up ... 2014. Revenue for the year ended December 31, 2015 was ...
(Date:2/4/2016)... 2016  Blueprint Medicines Corporation (NASDAQ: BPMC ... selective investigational kinase medicines for patients with genomically ... board of directors of Lonnel Coats , ... of industry-related experience. Jeffrey Albers ... strong strategic experience developing and commercializing numerous oncology ...
Breaking Medicine Technology:
(Date:2/6/2016)... ... 2016 , ... Research has shown that building shame resilience ... and level of relapse. , At the 2016 iaedp Symposium, the ... the critical tasks of the recovery phase and beyond including relapse prevention and ...
(Date:2/5/2016)... ... February 05, 2016 , ... Love is in the ... a variety of colors, assortments and packaging. This staple for Valentine’s Day is a ... location. , For Valentine’s Day, not only are long-stem roses available, but also ...
(Date:2/5/2016)... City, UT (PRWEB) , ... February 05, 2016 , ... ... Whole-Food Nutrition , announced that the much-anticipated feature with author Jahnavi Foster, specialist in ... Humans Amateur TV Network. , Each week, on his weekly Whole-Food Warrior TV show, ...
(Date:2/5/2016)... ... February 05, 2016 , ... The event is being held ... Event Center in Minneapolis, Minn. Triumph Over Parkinson’s will fund nearly $100,000 for research ... Schneiderman’s Furniture, lives with Parkinson’s disease and is the architect of this informative event ...
(Date:2/5/2016)... Santa Rosa, CA (PRWEB) , ... February 05, ... ... are pleased to announce the addition of micro-needling services in their Napa Valley ... appearance. The founders of Plastic Surgery Associates, Dr. Canales and Dr. Furnas, are ...
Breaking Medicine News(10 mins):